Stockreport

Foundation Medicine Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Compan...

FOUNDATION MEDICINE  (FMI) 
Last foundation medicine earnings: 5/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.foundationmedicine.com
PDF -- FoundationOne CDx is the First Next Generation Sequencing Test for All Solid Tumors to Complete the FDA/CMS Parallel Review Process and Launch with Na [Read more]